首页|免疫调节剂在儿童多发性寻常疣中的应用

免疫调节剂在儿童多发性寻常疣中的应用

扫码查看
原文链接
  • NETL
  • NSTL
  • 万方数据
目的：：研究免疫调节剂对儿童多发性寻常疣的治疗效果。方法：研究对象为2012年9月~2013年9月皮肤科门诊接收治疗的58例多发性寻常疣患儿，观察组（29例）接受免疫调节剂治疗，对照组（29例）接受γ干扰素治疗，经不同药物治疗后进行临床疗效的比对。结果：观察组治疗总有效率为89.66%，不良反应率为10.34%；对照组总有效率为55.17%，不良反应率为27.59%。组间比较χ2=30.56、10.47，统计学具有明显的差异性。结论：免疫调节剂对儿童多发性寻常疣的治疗效果优于γ干扰素，同时不良反应发生率低，安全性高，具有较高的临床使用价值。
objective to study the immune regulator treatment effect of children's multiple verruca vulgaris. Method the research ob-ject for the September 2012 to September 2013 dermatology clinics receiving treatment of 58 cases of children with multiple verruca vulgaris, observation group (29 cases) treated with immune regulator, the control group (29 cases) treated with gamma interferon, after treatment with different drugs for clinical curative effect of the comparison. Results observation group treatment the total effective rate was 89.66%, the adverse reaction rate was 10.34%; The control group total effective rate was 55.17%, the adverse reaction rate was 27.59%. Comparison between groupχsquared=30.56, 10.47, statistics has obvious difference. Conclusion of immune modulators in the treatment of children's multiple verruca vulgaris is better than gamma interferon, at the same time, low incidence of adverse reactions,high security, high value of clinical use.

immune modulatorsGamma interferonChildren's multiple verruca vulgaris

冉颖、葛宏松、张成、周洁

展开 >

安徽省儿童医院皮肤科 230051

免疫调节剂 γ干扰素 儿童多发性寻常疣

2015

延边医学

延边医学

ISSN：
年,卷(期)：2015.(7)
  • 6